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Abstract
Background: Vitamin D has been known since the twentieth Century for its benefits in bone health. Recent
observational studies have demonstrated its benefits in infectious diseases such as tuberculosis and non-communicable
diseases such as diabetes mellitus, cardiovascular diseases and cancer. This has led to a dramatic increase in testing
among adults.
The cut-offs for vitamin D deficiency have been debated for decades and the current cut off is derived from a Caucasian
population. Studies done among black African adults in Africa are few with vitamin D deficiency ranging from 5
to 91%. A few cut- offs have correlated vitamin D deficiency to physiological markers such as parathyroid hormone
(PTH), calcium and phosphate with varying results.
Methods: This was a cross sectional study carried out among blood donors at Aga Khan University hospital, Nairobi
(AKUHN) from March to May 2015. Vitamin D (25(OH)D) levels were assayed and correlated with PTH, calcium and
phosphate.
Results: A total of 253 individuals were included in the final analysis. The proportion of study participants who had a
25(OH) D level of < 20 ng/ml thus classified as vitamin D deficient was 17.4% (95% C.I 12.73–22.07). The 25(OH) D level
that coincided with a significant increase in PTH was 30 ng/ml.
Males were less likely to be vitamin D deficient (O.R 0.48 (C.I 0.233–0.993) p 0.04). Sunshine exposure for ≥3 h per day
reduced the odds of being Vitamin D deficient though this was not statistically significant after multivariate regression
analysis.
Conclusions: We found a much lower prevalence of Vitamin D deficiency compared to many similar studies carried
out in sub-Saharan Africa possibly due to the recruitment of healthy individuals and the proximity of Nairobi to the
equator which allows for considerable exposure to sunshine. Vitamin D levels below 30 ng/mL was associated with a
significant rise in PTH levels, suggesting that this cut off could be appropriate for defining Vitamin D deficiency in the
population served by our laboratory.
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Background
Vitamin D is a prohormone, which is widely known for
its role in bone health [1]. Observational studies in the
last decade have implicated its role in reducing the risk
of non-communicable diseases such as cancers, autoimmune diseases, cardiovascular diseases, disorders of
glucose metabolism, neurodegenerative diseases and communicable diseases [2–4].
Due to the increasing evidence of the importance of vitamin D in relation to various health outcomes, many clinical
laboratories in the USA have seen requests for vitamin D
testing increase by up to 100% [5]. We have observed similar increments in the requests for vitamin D determination
at the Aga Khan University Hospital, Nairobi laboratory.
Africa is a heterogeneous continent that straddles the
equator and has northern and southern temperate zones.
Most countries in the continent enjoy sunshine all year
round due to their proximity to the equator [6]. Data on
vitamin D levels among healthy Africans is scant with
vitamin D deficiency ranging from 5 to 91% and mean
vitamin D levels ranging from 4.4–46.1 ng/ml [7–10].
These studies however used different cut offs to define
vitamin D deficiency making direct comparisons on its
prevalence difficult. Majority did not correlate Vitamin
D levels to surrogate markers of physiological deficiency
such as calcium, phosphate and PTH and had insufficient sample sizes.
Other factors that influence the production of vitamin
D3 by the skin include the melanin content of the skin,
use of sunscreens, time of day, season, air pollution, cloud
cover, age and the extent of clothing covering the body
[11, 12]. Thus due to high melanin content (skin type
V-VI) among Africans, vitamin D production is not as efficient as in light skinned individuals (skin type I-IV) [13].
However most African countries enjoy sunshine throughout the year. The use of sunscreens reduces the absorption
of UVB radiation. Sun protection factor (SPF 30) reduces
vitamin D3 synthesis by more than 95%. Increasing age
reduces the amount of 7-dehydrocholesterol in the skin
leading to less production of vitamin D3 [12]. Season,
latitude and time of day affects the amount of solar UVB
photons reaching the earth thus affecting vitamin D3 production by the skin [11].
We therefore sought to determine the vitamin D status of
Kenyan blood donors of African origin and explore the possible risk factors for vitamin D deficiency. We also determined whether vitamin D deficiency as determined using
published cut offs translated into a functional deficiency by
assaying PTH, total calcium and inorganic phosphate.
Methods
Study design and site

This was a cross sectional study involving blood donors
that was conducted at the AKUH,N Kenya blood donor
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unit from March to May 2015. AKUH,N is a private
referral hospital that caters for the residents of Nairobi,
Kenya and the greater East African region and receives
400–500 blood donors per month. Nairobi is located at
latitude 1018’S and experiences sunshine throughout the
year due to its proximity to the equator.
Study participants

Blood donors of African origin between the ages of 18–
65 years who met the criteria of blood donation as per
the hospital policies were eligible to join the study. It
was assumed that those who met the strict criteria for
qualifying as a blood donor were healthy. Consecutive
sampling was used until the desired sample size was
achieved. Blood donors with a positive HIV, hepatitis B,
hepatitis C, malaria or syphilis result were excluded from
the final analysis.
Data collection

Upon obtaining an informed written consent, the study
participants filled a questionnaire. Its purpose was to collect
information regarding sun exposure, which was expressed
in terms of the number of hours spent outside, dietary
intake of vitamin D rich foods such as oily fish and dietary
intake of calcium and phosphate rich foods. This was in
addition to the blood donor screening questionnaire that
checks whether one is fit to qualify as a blood donor based
on appropriate age, weight, haemoglobin level, exposure to
infectious diseases and medication intake.
Sample collection and processing

Blood samples were collected in EDTA tubes for PTH
and 25(OH) D and serum clot activator tubes for total
calcium, inorganic phosphate and albumin. Centrifugation
was done immediately at 4000 rpm for 5 min. Plasma and
serum was then aliquoted into 2 ml plastic tubes and
stored at -20 °C and analysed in batches of 50.
Sample analysis

All samples were analysed on the ROCHE COBAS ®
platform e601 for PTH, 25(OH) D and e501 for total
calcium, inorganic phosphate and albumin. Analysis of
25 (OH) D was done using an electrochemiluminescent
competitive immunoassay assay and reported in nanograms
per milliliter (ng/ml). PTH was analysed using an electrochemiluminescent sandwich immunoassay and reported
in picograms/milliliter (pg/ml). Serum calcium and phosphate levels were measured photometrically using the
o-cresolphthalein complexone and molybdate methods
respectively and reported in mmol/l. Serum albumin was
analysed using a calorimetric assay and reported in in g/l.
Daily quality controls were within acceptable ranges. All
analytes had been registered under the Randox International
Quality Assessment Scheme (RIQAS) with acceptable
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running means standard deviation index of − 0.21,-0.80,
-0.44,-0.30,0.03 for 25 (OH) D, PTH, Calcium, phosphate
and albumin respectively.
Vitamin D levels were categorized as sufficient (> 30 ng/ml),
insufficient (21-29 ng/ml) and deficient (< 20 ng/ml)
based on the IOM classification that has been widely
adopted globally. The reference ranges for PTH were
15-65 pg/ml, total calcium 2.1–2.66 mmol/l, inorganic
phosphate 0.84–1.45 mmol/l. Corrected calcium was calculated for all study participants who had a low albumin level
and this was used in the final analysis.
Statistical analysis

Data was analysed using IBM® SPSS® Statistics V22.0.
The prevalence of vitamin D deficiency was expressed as
a percentage with 95% confidence intervals (CI). Continuous variables i.e. 25(OH)D, PTH, phosphate and calcium
were presented in form of medians and inter quartile
ranges.
A scatter plot was used to determine the relationship
between vitamin D and PTH and a quadratic equation
was used to arrive at the level of vitamin D beyond which
a decline resulted in an increase in PTH levels. This was
determined using the point of inflection on the graph.
Man Whitney U test was used to compare medians or
mean ranks of calcium and phosphate levels between
the vitamin D deficient (25(OH)D levels of < 20 ng/ml)
and non-deficient group (25(OH)D levels of ≥20 ng/ml).
Binary logistic regression and multivariate regression
analysis was used to calculate crude and adjusted odds
ratios for risk factors of vitamin D deficiency. These risk
factors included sunshine exposure in hours, gender and
dietary intake of oily fish. Age was not adjusted for, since
there was no statistically significant difference between
the vitamin D deficient and non-deficient group. A p
value < 0.05 was considered statistically significant.

Results
A total of 258 participants were recruited into the study
of whom 5 were excluded from the final analysis due to
a positive screen for HIV, Hepatitis B or C virus.
The median (IQR) age of the study participants was
33.07(40) years. Overall 62 (24.5%) of the study participants were female.
Table 1 shows the baseline demographic and biochemical variables of the study participants.
Vitamin D status

Study participants who were classified as vitamin D deficient (levels < 20 ng/ml) was 17.4% (95% C.I 12.73–
22.07). Those classified as vitamin D insufficient were
42.6% (95% C.I 36.51–48.69) while 40% (95% C.I 33.96–
46.04) were classified as vitamin D sufficient. Figure 1
shows the distribution of vitamin D levels.
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Males were less likely to be vitamin D deficient (O.R
0.481(C.I 0.233–0.933) p = 0.04). Sunshine exposure for
> 3 h significantly reduced the odds of one been vitamin
D deficient however this was not statistically significant
after multivariate regression analysis. The use of sunscreens and dietary intake of oily fish did not significantly increase or reduce the odds of one been vitamin
D deficient respectively though the numbers in these
categories were very small as shown in Table 2.
There was an inverse relationship between vitamin D
levels and PTH and the vitamin D level that coincided
with a significant increase in PTH was 30 ng/ml as
shown in Fig. 2.
There was no statistically significant difference in calcium
and phosphate levels between the vitamin D deficient and
non- deficient individuals.

Discussion
The prevalence of vitamin D deficiency was 17.4% (95% C.I
12.73–22.07). This study population was representative of a
healthy black African population in Kenya and despite
being vitamin D deficient they did not have any related
symptomatology. Furthermore, there was no statistically
significant difference in calcium and phosphate levels
between the vitamin D deficient non-deficient individuals.
This puts into question whether levels below 20 ng/mL
should trigger a medical intervention in the absence of
related symptomatology.
The prevalence we found in our study is in stark contrast to a study done by Luxwolda et al. in Tanzania on
the Hadzabe’s and Maasai’s who had a mean vitamin D
of 46.1 ng/ml with none of the participants being vitamin
D Deficient [8]. The difference in vitamin D levels might
have been due to the fact that Maasai’s and Hadzabe’s are
pastoralists’, hunters and gatherers and spend most of their
time outdoors with minimal clothing.
The US National Nutrition and Health survey (NHANES)
III reported that at least 53–76% of African Americans were
vitamin D deficient during winter [14] and Powe et al. reported a mean vitamin D level of 15 ± 0.2 ng/ml among
1181 black Americans [15]. The reasons cited for this level
of deficiency included dark skin colour thus resulting in
inefficient vitamin D production by the skin and lack of
regular vitamin D supplementation.
We found that females were more likely to be vitamin
D deficient. Possible explanations for this observation include increased subcutaneous adiposity and higher Body
mass index (BMI) among females resulting in increased
25(OH) D storage in adipose tissue thus not readily
available for conversion to calcitriol [16]. Subcutaneous
adiposity and BMI were however not taken for the study
participants.
Studies have been done correlating vitamin D to physiological markers of vitamin D deficiency such as PTH,

Kagotho et al. BMC Endocrine Disorders (2018) 18:70

Page 4 of 7

Table 1 Descriptive characteristics of the study participants
Male (n = 191)

Female (n = 62)

Total (n = 253)

Male vs female

Median(IQR)

Min-Max

Median (IQR)

Min-Max

Median (IQR)

Min-Max

p- value

Age (years)

33 (40)

19–59

31 (30)

21–51

33.07 (40)

19–59

0.304

Vitamin D (ng/ml)

28.24 (44.47)

8.89–53.36

25.08 (34.12)

8.57–42.71

27.80 (44.79)

8.57–53.36

0.002

PTH (pg/ml)

36.46 (72.69)

10.38–83.07

36.71 (83.38)

16.72–100.1

36.7 (89.72)

10.38–100.1

0.534

Calcium (mmol/l)

2.42 (1.50)

1.23–2.73

2.38 (0.72)

2.05–2.77

2.41 (1.54)

1.23–2.77

0.168

Phosphate (mmol/l)

1.17 (3.32)

0.66–3.98

1.17 (2.58)

0.82–3.40

1.13 (3.32)

0.66–3.98

0.360

IQR interquartile range

calcium and phosphate. These studies have reported
that PTH is inversely associated with vitamin D and
begins to plateau at a vitamin D level between 16 and
40 ng/ml [17–19]. This is the lowest vitamin D level
beyond which PTH starts rising. Whether these values
would be suitable cut-offs still remains controversial.
The US Institute of Medicine 2011 guidelines quoted
that one of the reasons behind the current recommendation of the cut off 20 ng/ml to define deficiency was
the lowest vitamin D level at which PTH started rising
[17]. From our study, the derived vitamin D cut-off
based on the point of inflection i.e. the vitamin D level
when PTH starts rising is 30 ng/ml. This was similar to
a cross-sectional study done by Nusrat et al. in Kenya,
unpublished data who looked at vitamin D levels and
PTH in exclusively 97 breast fed infants and came up
with a cut-off of 30 ng/ml. If a cut off of 30 ng/ml was

Fig. 1 Distribution of vitamin D levels

adopted then 60.1% (95% C.I. 54.07–66.13%) of the
study population would have been vitamin D deficient.
This raises the question whether there are other factors
such as bioavailable vitamin D and vitamin D binding protein that should be considered when interpreting 25(OH)
D levels since this was essentially a healthy population.
This was reported in a study by Powe et al. where Black
Americans compared to whites had low Vitamin D levels
(15.6 ± 0.2 ng/ml vs. 25.8 ± 0.4 ng/ml, P < 0.001) and
vitamin D binding protein (168 ± 3 μg/ml vs. 337 ±
5 μg/ml, P < 0.001) but similar concentrations of bioavailable Vitamin D 2.9 ± 0.1 ng/ml vs 3.1 ± 0.1 ng/ml, P = 0.71.
Genetic polymorphisms partially explained the differences
in Vitamin D binding protein in the two populations [15].
Sunshine exposure for ≥3 h was associated with a decreased likelihood of being vitamin D deficient as compared
to < 1 h. This was however not statistically significant using
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Table 2 Comparison of risk factors for Vitamin D deficiency
P value

Crude O.R (C.I)

P value

Adjusted O.R. (C.I)

0.03

0.463 (0.212–0.784)

0.04

0.481 (0.233–0.933)

13 (18.6%)

0.48

0.753 (0.344–0.1647)

0.13

0.893 (0.0.658–4.912)

11 (11.3%)

0.03

0.422 (0.189–0.942)

0.08

0.623 (0.487–3.889)

0.20

0.642 (0.231–1.281)

0.75

0.782 (0.169–3.623)

Deficient

Non-deficient

Femalea

17 (27.4%)

45 (72.6%)

Male

27 (14.1%)

164 (85.9%)

≤ 1 h dailya

66 (76.7%)

20 (23.3%)

1–3 h daily

57 (81.4%)

> 3 h daily

86 (88.7%)

Gender: N (%)

Sunshine exposure: N (%)

Oily fish intake: N (%)
Nonea

30 (19.9%)

121 (80.1%)

≥ once a week

14 (13.7%)

88 (86.3%)

Nonea

42 (17.6%)

197 (82.4%)

Yes

2 (14.3%)

12 (85.7%)

Sunscreen use: N (%)

a

Reference group, O.R Odds ratio, C.I Confidence interval

multiple logistic regression. More than 95% of vitamin D 3
is from the sun [20]. Nairobi lies at latitude 1018’S thus
enjoying sunshine all year round. Increased skin pigmentation reduces the production of vitamin D 3 on the skin.
Since most Africans are skin type V and VI longer sunshine
exposure would be required to make vitamin D 3.
Sunscreen use increases the risk of vitamin D deficiency,
with sunscreens with an SPF of 30 and above reducing
vitamin D production by upto 95% [20]. From this study
14 out of the 253 study participants reported the use of
sunscreen or sunscreen containing lotions and there was
no statistically significant difference in vitamin D levels
between those who did and didn’t use sunscreen. This

Fig. 2 Scatter plot showing the relationship of vitamin D and PTH

study was however not sufficiently powered to test for this
association.

Limitations

This study was not sufficiently powered to show significant differences for the different risk factors and as such,
most of the analysis was exploratory. The absence of statistically significant differences could be due to the small
sample size, which increases the risk of a type II error.
Sun exposure, use of sunscreens and dietary intake of
vitamin D and calcium rich foods data collected for this
study was self-reported thus liable to a reporting bias.
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Skin type for the study participants was also not determined. Potentially, variation in skin types could influence
the impact of some risk factors on Vitamin D levels.
Factors that can affect vitamin D levels such as Vitamin
D supplementation, Body Mass Index (BMI) and subcutaneous adiposity were not taken.

statistical analysis and critiqued the manuscript. All authors read and
approved the final manuscript.

Conclusion
This study highlights that one in every six healthy Kenyan
adults of African origin donating blood at AKUHN is
vitamin D deficient using the cut-off of 20 ng/ml. These
adults had no signs and symptoms of deficiency and
biochemically appeared not to have any significant abnormality. Clinicians need to be aware of the level of
deficiency in the healthy population so that they can
take this into account when interpreting Vitamin D results in patients. Whether such individuals should have
vitamin D supplementation to boost their levels above
30 ng/mL is a question that still needs to be answered.
Vitamin D testing should also be restricted to patients
at risk as per the Endocrine society 2011 guidelines. This
includes patients with osteoporosis, chronic kidney disease,
pregnant and lactating mothers, hyperparathyroidism and
malabsorption syndromes.
Studies being carried out linking vitamin D to various
health outcomes also need to bear in mind the baseline
level of deficiency in the healthy Kenyan population.
Suitable 25 (OH) D cut-offs need to be established in
the African population and these need to be predictive
of specific well defined outcomes. Since total vitamin D
and not the active form is what is routinely assayed, studies correlating 25(OH)D levels, vitamin D binding protein
and physiological markers of vitamin D deficiency among
Africans need to be done.
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